[Drug therapy in pacemaker patients].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006099:Granuloma / Q000188:drug therapy / Q000209:etiology; D006331:Heart Diseases / Q000188:drug therapy / Q000209:etiology; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D010138:Pacemaker, Artificial / Q000009:adverse effects*; D010672:Phenytoin / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy; D014665:Vasodilator Agents / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000317:Adrenergic alpha-Antagonists; D004071:Digitalis Glycosides; D014665:Vasodilator Agents; D010672:Phenytoin
Pharmakotherapie bei Schrittmacher-Patienten